tag:blogger.com,1999:blog-7857054149675424609.post3881744124691400853..comments2024-02-24T08:58:08.581+00:00Comments on RNAi Therapeutics: The Wall Street Journal Reports that ‘Big Pharma Faces a Grim Prognosis’- In what Form will it take its RNAi Pill?Dirk Hausseckerhttp://www.blogger.com/profile/18320439857875629714noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-7857054149675424609.post-26834183915256171272007-12-12T16:02:00.000+00:002007-12-12T16:02:00.000+00:00As a 'lay' Alnylam shareholder I welcome your info...As a 'lay' Alnylam shareholder I welcome your informed analysis of the big pharma scenario. I believe, as you do it seems, that the platform provided by growing understanding of protein synthesis in biology offers a launching pad, 'the best way to go', for big Pharma. Alnylam, with its comprehensive IP portfolio, is the gatekeeper. I try to keep abreast of developments in the technology and the construerhttps://www.blogger.com/profile/11822782023394332906noreply@blogger.com